Anti-T Lymphocyte Globulin (ATLG) Improves Quality of Life (QoL) and Chronic Graft vs Host Disease and Relapse Free Survival (GRFS) after Allogeneic Hematopoietic Stem Cell Transplantation from Hla-Identical Sibling in Acute Myeloid Leukemia: Final Results of QoL and Long-Term Outcome Analysis of a Phase 3 Randomized Study | Publicación